• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对接、分子动力学和基于共识评分的虚拟筛选鉴定潜在的寨卡病毒 NS2B-NS3 蛋白酶抑制剂。

Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.

机构信息

California Polytechnic State University, 1 Grand Avenue, San Luis Obispo, CA, 93407, USA.

San Francisco State University, 1600 Holloway Avenue, San Francisco, CA, 94132, USA.

出版信息

J Mol Model. 2019 Jun 17;25(7):194. doi: 10.1007/s00894-019-4076-6.

DOI:10.1007/s00894-019-4076-6
PMID:31209577
Abstract

The Zika virus has recently become a subject of acute interest after the discovery of the link between viral infection and microcephaly in infants. Though a number of treatments are under active investigation, there are currently no approved treatments for the disease. To address this critical need, we screened more than 7 million compounds targeting the NS2B-NS3 protease in an attempt to identify promising inhibitor candidates. Starting with commercially and freely available compounds, we identified six hits utilizing an exhaustive consensus screening protocol, followed by molecular dynamics simulation and binding energy estimation using MM/GBSA and MM/PBSA methods. These compounds feature a variety of cores and functionalities, and all are predicted to have good pharmacokinetic profiles, making them promising candidates for screening assays. Graphical abstract Virtual screen of potential Zika virus NS2B-NS3 protease inhibitors.

摘要

寨卡病毒(Zika virus)在发现病毒感染与婴儿小头畸形之间的关联后,最近成为一个研究热点。尽管有许多治疗方法正在积极研究中,但目前尚无针对该疾病的批准治疗方法。为了满足这一迫切需求,我们筛选了超过 700 万个针对 NS2B-NS3 蛋白酶的化合物,试图确定有前途的抑制剂候选物。我们从商业上和免费获得的化合物开始,使用详尽的共识筛选方案确定了六个命中物,然后使用 MM/GBSA 和 MM/PBSA 方法进行分子动力学模拟和结合能估计。这些化合物具有多种核心和功能,并且都被预测具有良好的药代动力学特征,使它们成为筛选试验的有希望的候选物。

相似文献

1
Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.通过对接、分子动力学和基于共识评分的虚拟筛选鉴定潜在的寨卡病毒 NS2B-NS3 蛋白酶抑制剂。
J Mol Model. 2019 Jun 17;25(7):194. doi: 10.1007/s00894-019-4076-6.
2
Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs.基于结构的虚拟筛选 FDA 批准药物鉴定寨卡病毒 NS2B-NS3 蛋白酶和 NS5 聚合酶抑制剂。
J Biomol Struct Dyn. 2024 Sep;42(15):8073-8088. doi: 10.1080/07391102.2023.2242963. Epub 2023 Aug 1.
3
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.基于结构的已上市药物发现作为 Zika 病毒 NS2B-NS3 蛋白酶抑制剂,在体外和体内强效抑制 Zika 病毒感染。
Antiviral Res. 2017 Sep;145:33-43. doi: 10.1016/j.antiviral.2017.07.007. Epub 2017 Jul 14.
4
Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition. Zika 病毒 NS2B/NS3 蛋白酶:老药新靶——苏拉明是 NS2B/NS3 蛋白酶抑制剂的先导化合物。
Antiviral Res. 2018 Dec;160:118-125. doi: 10.1016/j.antiviral.2018.10.019. Epub 2018 Oct 28.
5
The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.通过整合虚拟筛选方法发现具有抗病毒活性的寨卡病毒 NS2B-NS3 抑制剂。
Eur J Pharm Sci. 2022 Aug 1;175:106220. doi: 10.1016/j.ejps.2022.106220. Epub 2022 May 23.
6
Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.利用虚拟筛选和生物分子模拟鉴定新型登革热病毒 NS2B/NS3 蛋白酶潜在抑制剂。
Int J Biol Macromol. 2024 Jun;272(Pt 1):132855. doi: 10.1016/j.ijbiomac.2024.132855. Epub 2024 Jun 2.
7
Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.靶向“超级开放”构象中蛋白酶的 Zika 病毒 NS2B-NS3 蛋白酶的别构抑制剂。
Viruses. 2023 Apr 30;15(5):1106. doi: 10.3390/v15051106.
8
Identification of novel Zika virus NS3 protease inhibitors with different inhibition modes by integrative experimental and computational approaches.通过综合实验和计算方法鉴定具有不同抑制模式的新型寨卡病毒NS3蛋白酶抑制剂。
Biochimie. 2023 Sep;212:143-152. doi: 10.1016/j.biochi.2023.04.004. Epub 2023 Apr 22.
9
Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.评价抗登革热植物化合物对 DENV-2 NS2B-NS3 蛋白酶的抑制活性:虚拟筛选、ADMET 分析和分子动力学模拟研究。
J Biomol Struct Dyn. 2024 Apr;42(6):2990-3009. doi: 10.1080/07391102.2023.2212798. Epub 2023 May 17.
10
Identification of potential ZIKV NS2B-NS3 protease inhibitors from : An insilico approach.从……中鉴定潜在的寨卡病毒NS2B-NS3蛋白酶抑制剂:一种计算机模拟方法。
J Biomol Struct Dyn. 2022;40(21):11203-11215. doi: 10.1080/07391102.2021.1956592. Epub 2021 Jul 28.

引用本文的文献

1
Towards Effective Consensus Scoring in Structure-Based Virtual Screening.迈向基于结构的虚拟筛选中有效的共识评分。
Interdiscip Sci. 2023 Mar;15(1):131-145. doi: 10.1007/s12539-022-00546-8. Epub 2022 Dec 23.
2
Ellagic Acid as a Potential Inhibitor against the Nonstructural Protein NS3 Helicase of Zika Virus: A Molecular Modelling Study.鞣花酸作为寨卡病毒非结构蛋白 NS3 解旋酶抑制剂的潜力:一项分子建模研究。
Biomed Res Int. 2022 Aug 21;2022:2044577. doi: 10.1155/2022/2044577. eCollection 2022.
3
WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches.

本文引用的文献

1
Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.结构洞察小分子抑制剂对寨卡病毒 NS2B-NS3 蛋白酶的抑制作用。
Structure. 2018 Apr 3;26(4):555-564.e3. doi: 10.1016/j.str.2018.02.005. Epub 2018 Mar 8.
2
Zika Virus Protease: An Antiviral Drug Target. Zika 病毒蛋白酶:抗病毒药物靶点。
Trends Microbiol. 2017 Oct;25(10):797-808. doi: 10.1016/j.tim.2017.07.001. Epub 2017 Aug 5.
3
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
基于WaterMap和分子动力学模拟,采用药物重利用方法发现潜在的PAK1抑制剂
ACS Omega. 2021 Oct 5;6(41):26829-26845. doi: 10.1021/acsomega.1c02032. eCollection 2021 Oct 19.
4
Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses.基于结构的虚拟筛选:鉴定一种对寨卡病毒和登革热病毒具有强效抗病毒活性的新型NS2B-NS3蛋白酶抑制剂。
Microorganisms. 2021 Mar 6;9(3):545. doi: 10.3390/microorganisms9030545.
基于结构的已上市药物发现作为 Zika 病毒 NS2B-NS3 蛋白酶抑制剂,在体外和体内强效抑制 Zika 病毒感染。
Antiviral Res. 2017 Sep;145:33-43. doi: 10.1016/j.antiviral.2017.07.007. Epub 2017 Jul 14.
4
Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.寨卡病毒 NS2B-NS3 蛋白酶与二肽抑制剂结合的结构动力学。
Structure. 2017 Aug 1;25(8):1242-1250.e3. doi: 10.1016/j.str.2017.06.006. Epub 2017 Jul 6.
5
Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening.基于结构的虚拟筛选中,机器学习共识评分提高了跨靶点的性能。
J Chem Inf Model. 2017 Jul 24;57(7):1579-1590. doi: 10.1021/acs.jcim.7b00153. Epub 2017 Jul 12.
6
Vaccination strategies against Zika virus.针对寨卡病毒的疫苗接种策略。
Curr Opin Virol. 2017 Apr;23:59-67. doi: 10.1016/j.coviro.2017.03.006. Epub 2017 Apr 19.
7
Epidemic arboviral diseases: priorities for research and public health.虫媒病毒性传染病:研究和公共卫生的优先事项。
Lancet Infect Dis. 2017 Mar;17(3):e101-e106. doi: 10.1016/S1473-3099(16)30518-7. Epub 2016 Dec 21.
8
Crystal structure of unlinked NS2B-NS3 protease from Zika virus.寨卡病毒非连接型 NS2B-NS3 蛋白酶的晶体结构。
Science. 2016 Dec 23;354(6319):1597-1600. doi: 10.1126/science.aai9309. Epub 2016 Dec 8.
9
Structure of the NS2B-NS3 protease from Zika virus after self-cleavage.结构的 NS2B-NS3 蛋白酶从寨卡病毒后自我切割。
Nat Commun. 2016 Nov 15;7:13410. doi: 10.1038/ncomms13410.
10
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.通过药物再利用筛选鉴定寨卡病毒感染及诱导神经细胞死亡的小分子抑制剂。
Nat Med. 2016 Oct;22(10):1101-1107. doi: 10.1038/nm.4184. Epub 2016 Aug 29.